Hutch News
Results per Page:
Researchers refine experimental gene therapy for herpes
Treatment sharply reduced viral shedding in laboratory mice
Dr. Anna Wald lauded by Infectious Diseases Society
Virologist will deliver prestigious John F. Enders Lecture during annual conference
Herpes simplex virus mistyping due to inter-species recombination
From the University of Washington, the Vaccine and Infectious Disease Division
Despite early rise, longterm ART decreases HSV shedding
From the Corey lab, Vaccine and Infectious Disease Division
Models aren’t just pretty
From the Schiffer lab, Vaccine and Infectious Disease Division
Experimental herpes drug pritelivir more effective than standard treatment
Pritelivir reduces viral shedding and lesions better than valacyclovir, study shows
Halting herpes' transmission
New Hutch study predicts threshold of viral load for passing herpes from one person to another
Genital herpes can spread even when lesions aren't present
Largest study of herpes simplex virus type 2 to date finds asymptomatic carriers can transmit virus to partners
Riddell, Wald elected to Association of American Physicians
Honor recognizes contributions of physician-scientists
Proof in packaging
Virologist Anna Wald's research shows herpes risk cut in half for consistent condom users, lends substance to debate over labeling
Stemming the spread of STD's
International center-led trial finds that a daily dose of an antiviral drug halves transmission of genital herpes, may lessen other STD infections